Stellar Biotechnologies Announces Joint Research on Clostridium Difficile Immunotherapy Accepted for Presentation
July 24, 2013 18:01 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Jul 24, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that a preclinical abstract on...
Stellar Biotechnologies Presents at Annual 2013 National Science Foundation Conference
May 28, 2013 09:00 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - May 28, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of a poster at...
Stellar Biotechnologies to Present at the Second Annual Marcum LLP Microcap Conference
May 21, 2013 09:33 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - May 21, 2013) - Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that Frank Oaks, President & CEO and Darrell Brookstein,...
Stellar Biotechnologies Announces Publication of "Expert Review" Article on Clostridium Difficile Vaccines
April 30, 2013 09:00 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - Apr 30, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of Keyhole...
Stellar Biotechnologies Submits Biological Master File to U.S. FDA for Subunit KLH
March 19, 2013 09:15 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Mar 19, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of...
Stellar Biotechnologies Announces Preclinical Poster at Society of Toxicology (SOT) Showing That Forms and Sources of KLH Matter
March 13, 2013 09:10 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Mar 13, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of results from a...
Stellar Biotechnologies Exceeds Aquaculture Capacity Goals
February 19, 2013 08:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Feb 19, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company exceeded its 2012 plan...
Stellar Biotechnologies Files Provisional Application for Patent for KLH Adjuvant Innovations
February 06, 2013 10:36 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Feb 6, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company has submitted a...
Stellar Biotechnologies Pioneers Aquaculture Milestone in KLH Protein Manufacturing
January 22, 2013 08:55 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jan 22, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company has successfully...
Stellar Biotechnologies to Present at Noble Financial Capital Markets Ninth Annual Equity Conference January 23, 2013
January 17, 2013 09:35 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jan 18, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of...